Covax(Search results - 96)
Top StoriesSep 13, 2021, 6:52 PM IST
WHO likely to approve Bharat Biotech's Covaxin this week: Report
The WHO’s emergency approval will allow Bharat Biotech to export Covaxin and also ease international travel of people who have received this vaccine.
TechnologySep 1, 2021, 6:23 PM IST
Google Maps, Assistant, Search to offer details of vaccine availability
According to Google, immunisation assistance will be provided in over 13,000 sites around the country. The availability of appointment slots at each facility, whether the centre offers Dose 1 or Dose 2 of the appropriate vaccinations (Covishield, Covaxin, or others), and any price information, if applicable, will be supplied.
Top StoriesAug 12, 2021, 6:56 PM IST
Union Health Minister Mandaviya meets WHO chief scientist Dr Soumya Swaminathan over WHO's approval of Covaxin
A week ago, Bharat Biotech received Good Manufacturing Practices (GMP) compliance certificate from Hungary in the manufacturing of Covaxin.
Top StoriesAug 10, 2021, 4:56 PM IST
Bharat Biotech's Ankleshwar plant gets government’s approval for manufacturing Covaxin
The Minister said that this move will help ramp up availability of the indigenous vaccine to speed up the national vaccination drive.
Top StoriesAug 8, 2021, 11:31 AM IST
ICMR study: Mixing and matching Covaxin and Covishield shows better result
The study noted vaccination using a combination of an adenovirus vector platform-based vaccine and an inactivated whole-virus vaccine elicited better immunogenicity.
Top StoriesAug 7, 2021, 2:23 PM IST
Johnson & Johnson gets Emergency Use Approval for its single-dose COVID-19 vaccine in India
India has so far approved four vaccines - AstraZeneca's Covishield, Bharati Biotech's Covaxin, Russian Gamaleya Institute's Sputnik V and Moderna's vaccine.
Top StoriesAug 5, 2021, 11:01 AM IST
India's Covaxin receives Good Manufacturing Practice certificate from Hungary: Bharat Biotech
With this approval, Bharat Biotech achieved another significant milestone in innovating and manufacturing vaccines at global quality standards and moving forward in the ongoing fight against the Covid-19 pandemic, read Bharat Biotech statement.
Top StoriesAug 2, 2021, 2:17 PM IST
Covaxin effective against Delta Plus variant of COVID-19, says ICMR study
Delta Plus variant of coronavirus is a global public health concern due to its impact on existing vaccines.
Top StoriesJul 24, 2021, 11:47 AM IST
Results of COVID vaccine trials for children likely by September: AIIMS chief Dr Randeep Guleria
AIIMS director Randeep Guleria has said that the trials of Bharat Biotech's Covaxin on children are presently underway and the results are expected by September.
Top StoriesJul 24, 2021, 11:36 AM IST
Bharat Biotech terminates Brazil’s Covaxin pact amid political dispute
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
Top StoriesJul 23, 2021, 9:34 AM IST
AIIMS Delhi to start second dose trial of Covaxin on 2-6 years old children by next week
The second dose of Covaxin has already been given to children aged between 6 to 12 years at AIIMS, Delhi, which is one of the centres for trials of the vaccine for those below 18 years.
Top StoriesJul 3, 2021, 11:28 AM IST
Bharat Biotech releases Phase 3 trial data, claims Covaxin is 77.8% effective
Bharat Biotech claimed that its vaccine offered 65.2% protection against the rapidly emerging Delta variant and 93.4% efficacy against severe symptomatic Covid-19.
Top StoriesJul 1, 2021, 10:01 AM IST
India urges European Union to accept Covishield, Covaxin or face mandatory quarantine
The EU countries accept only the vaccines approved by the European Medicines Agency, which are Pfizer, Moderna, AstraZeneca, and Janssen. But Covishield, which is the Indian version of AstraZeneca, is yet to get their clearance.
Top StoriesJul 1, 2021, 9:53 AM IST
Zydus Cadila applies for emergency use authorisation of its COVID-19 vaccine
An approval for Zydus’ vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca and partner Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Sputnik V developed by Russia’s Gamaleya Institute.
Top StoriesJun 30, 2021, 4:53 PM IST
From Covishield to Covaxin, Sputnik V and Moderna vaccine: Know dosage limit, duration, efficacy and more
To expand its mass vaccination program, the Indian government has now given clearance to Moderna vaccine thus providing a wider option for the public to choose between four vaccines. Earlier Covishield, Covaxin and Sputnik V were administered among the Indian population to contain the spread of Covid, now the Moderna vaccine will be added to that list.